Hoeffel C, Mulé S, Laurent V, Bouché O, Volet J, Soyer P
Department of Radiology, hôpital Robert-Debré, CHU de Reims, rue du Général-Kœnig, 51100 Reims, France.
Department of Radiology, hôpital Robert-Debré, CHU de Reims, rue du Général-Kœnig, 51100 Reims, France.
Diagn Interv Imaging. 2014 May;95(5):485-94. doi: 10.1016/j.diii.2014.03.005. Epub 2014 Apr 2.
The treatment of patients with a malignant rectal tumor has evolved over the past few years. The role of medical imaging techniques, notably MRI, has become increasingly important in the preoperative assessment of rectal tumors. Radiologists are finding that their presence is requested more and more frequently at multidisciplinary team meetings for decision-making on the treatment of these tumors and therefore they must have a grounding in the therapeutic issues involved. Locoregional assessment of malignant rectal tumors may be performed prior to initiating treatment or as a re-evaluation following neoadjuvant therapy. We are interested in the assessment of the initial locoregional extension of these rectal tumors and we place much emphasis on the ability to identify MRI criteria which determine the patient's prognosis and treatment. We will also examine the advantages of MRI as well as its limits in this assessment.
在过去几年中，恶性直肠肿瘤患者的治疗方法不断演变。医学影像技术，尤其是磁共振成像（MRI），在直肠肿瘤的术前评估中发挥着越来越重要的作用。放射科医生发现，在多学科团队会议上，越来越频繁地需要他们参与关于这些肿瘤治疗的决策，因此他们必须对所涉及的治疗问题有一定的了解。在开始治疗之前或在新辅助治疗后进行重新评估时，可以对恶性直肠肿瘤进行局部区域评估。我们关注这些直肠肿瘤初始局部区域扩展的评估，并非常重视识别决定患者预后和治疗的MRI标准的能力。我们还将研究MRI在该评估中的优势及其局限性。
